Total: £ 56.28
2025-11-07 | Pages: 150 | Tables: 159
The global Cord Blood Stem Cell Storage Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Cord blood stem cell storage ...
2025-11-07 | Pages: 157 | Tables: 156
The global Small Molecule Drug CDMO Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Small molecule drug CDMO service...
2025-11-07 | Pages: 139 | Tables: 135
The global Artificial Intelligence In Ultrasound Imaging market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.From a downstream pe...
2025-11-07 | Pages: 145 | Tables: 140
The global Therapeutic Intensive Care market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.From a downstream perspective, Adults a...
2025-11-07 | Pages: 138 | Tables: 142
The global RNA Gene Expression Sequencing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.RNA gene expression sequencing is a...
2025-11-07 | Pages: 158 | Tables: 147
The global Animal Primary Cells market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Human primary hepatocytes have the following ...
2025-11-07 | Pages: 122 | Tables: 120
The global Bioinformatics Sequencing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.From a downstream perspective, R...
2025-11-07 | Pages: 131 | Tables: 137
The global Extracellular Vesicles Based Liquid Biopsy market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.From a downstream persp...
2025-11-07 | Pages: 138 | Tables: 138
The global Sudden Eye Pain Relief Treatment market is projected to grow from US$ 440 million in 2024 to US$ 798 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications.Acute ocular pain, co...
2025-11-07 | Pages: 155 | Tables: 151
The global Skin Permeation Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Skin Permeation Testing is an experimental...
2025-11-07 | Pages: 171 | Tables: 170
The global In Vitro Permeation Testing (IVPT) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.In Vitro Permeation Testing (IV...
2025-11-07 | Pages: 119 | Tables: 119
The global Reconstructed human Epidermis (RhE) Model market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.The Reconstructed Human ...
2025-11-07 | Pages: 73 | Tables: 74
The global market for Exosome Technology Services was estimated to be worth US$ 22.6 million in 2024 and is forecast to a readjusted size of US$ 102 million by 2031 with a CAGR of 24.3% during the forecast period 2025-2031.Exosomes are a type of vesi...
2025-11-07 | Pages: 92 | Tables: 85
The global market for Uterine Fibroid Treatment was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.In China market, key players of uterine fib...
2025-11-07 | Pages: 99 | Tables: 86
The global market for Castrate Resistant Prostate Cancer Therapeutics was estimated to be worth US$ 18800 million in 2024 and is forecast to a readjusted size of US$ 39170 million by 2031 with a CAGR of 11.2% during the forecast period 2025-2031.Pros...